AAAAAA
Results:
1-10
|
Results: 10
Authors:
Neth, O
Hann, I
Turner, MW
Klein, NJ
Citation: O. Neth et al., Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study, LANCET, 358(9282), 2001, pp. 614-618
Authors:
Poon, MC
d'Oiron, R
Hann, I
Negrier, C
de Lumley, L
Thomas, A
Karafoulidou, A
Demers, C
Street, A
Huth-Kuhne, A
Petrini, P
Fressinaud, E
Morfini, M
Tengborn, L
Marques-Verdier, A
Musso, R
Devecioglu, O
Houston, DS
Lethagen, S
Van Geet, C
von Depka, M
Berger, C
Beurrier, P
Britton, HA
Gerrits, W
Guthner, C
Kuhle, S
Lorenzo, JJ
Makris, PE
Nohe, N
Paugy, P
Pautard, B
Torchet, MF
Trillot, N
Vicariot, M
Wilde, J
Winter, M
Chambost, H
Ingerslev, J
Peters, M
Strauss, G
Citation: Mc. Poon et al., Use of recombinant factor VIIa (NovoSeven (R)) in patients with Glanzmann thrombasthenia, SEM HEMATOL, 38(4), 2001, pp. 21-25
Authors:
Hann, I
Vora, A
Harrison, G
Martineau, M
Moorman, AV
Walker, LMS
Eden, O
Hill, F
Gibson, B
Richards, S
Citation: I. Hann et al., Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol (vol 113, pg 103, 2001), BR J HAEM, 113(3), 2001, pp. 844-844
Authors:
Hann, I
Vora, A
Harrison, G
Harrison, C
Eden, O
Hill, F
Gibson, B
Richards, S
Citation: I. Hann et al., Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol, BR J HAEM, 113(1), 2001, pp. 103-114
Authors:
Ljung, R
Aronis-Vournas, S
Kurnik-Auberger, K
Van den Berg, M
Chambost, H
Claeyssens, S
Van Geet, C
Glomstein, A
Hann, I
Hill, F
Kobelt, R
Kreuz, W
Mancuso, G
Muntean, W
Petrini, P
Rosado, L
Scheibel, E
Siimes, M
Smith, O
Tusell, J
Citation: R. Ljung et al., Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries, HAEMOPHILIA, 6(6), 2000, pp. 619-624
Authors:
Salooja, N
Martin, P
Khair, K
Liesner, R
Hann, I
Citation: N. Salooja et al., Severe factor V deficiency and neonatal intracranial haemorrhage: a case report, HAEMOPHILIA, 6(1), 2000, pp. 44-46
Authors:
Hann, I
Vora, A
Richards, S
Hill, F
Gibson, B
Lilleyman, J
Kinsey, S
Mitchell, C
Eden, OB
Citation: I. Hann et al., Benefit of intensified treatment for all children with acute lymphoblasticleukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials, LEUKEMIA, 14(3), 2000, pp. 356-363
Authors:
Ancliff, P
Liesner, R
Khair, K
Hann, I
Citation: P. Ancliff et al., The use of recombinant factor VIIa in a patient with severe Glanzmann's thrombasthenia to facilitate insertion of a Port-a-Cath (R), BL COAG FIB, 10(7), 1999, pp. 447-448
Authors:
Atherton, DJ
Cox, I
Hann, I
Citation: Dj. Atherton et al., Intravenous iron (III) hydroxide-sucrose complex for anaemia in epidermolysis bullosa, BR J DERM, 140(4), 1999, pp. 773-773
Authors:
Liesner, R
Mackie, I
Cookson, J
McDonald, S
Chitolie, A
Donohoe, S
Evans, J
Hann, I
Machin, S
Citation: R. Liesner et al., Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion, BR J HAEM, 103(4), 1998, pp. 1037-1044
Risultati:
1-10
|